Meeting Banner
Abstract #0968

Multiparametric MR imaging for the assessment of prostate cancer aggressiveness at 3 Tesla

Eline K. Vos 1 , Thiele Kobus 1 , Geert Litjens 1 , Thomas Hambrock 1 , Christina Hulsbergen-van de Kaa 2 , Marnix Maas 1 , and Tom Scheenen 1

1 Radiology, Radboud university medical center, Nijmegen, Gelderland, Netherlands, 2 Pathology, Radboud university medical center, Nijmegen, Gelderland, Netherlands

Multiparametric MRI (mpMRI) was evaluated for the assessment of prostate cancer aggressiveness. For the peripheral zone only the ADC calculated from DWI should be used in combination with anatomical T2-weighted imaging. In the transition zone, both pharmacokinetic parameters (Ktrans and Kep) derived from DCE-MRI and metabolite ratios (CC/C and C/C) from MRSI may be useful additions to T2-weighted imaging and DWI for the discrimination of indolent versus significant PCa

This abstract and the presentation materials are available to members only; a login is required.

Join Here